SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1531>>Medicare Modifies Proposed Coverage Change For Anemia Drugs Last update:tuck-7/30/2007
1530Amgen beats by 6 cents, and is slightly above consensus on revenue. No guidancetuck-7/26/2007
1529FDA Panel to Discuss Amgen, J&J Anemia Drugs By JENNIFER CORBETT DOOREN JuDoc Bones-7/23/2007
1528The trial has not started. Roche/amgn are trying to add claims in and throw out david nordic-7/20/2007
1527the initial news is bad for roche, but amgn is not out of the woods...mopgcw-7/19/2007
1526Helix could be put on hold "Whatever they can cut, they'll cut," Mike McFarland-7/19/2007
1525Exactly what does this mean?steve kammerer-7/18/2007
1524Thanks, should be good for Amgen. They only need one of theirs to hold up. Pletuck-7/18/2007
1523judge denies 6 of the 14 motions.... docket No Made Motion Action Motion 473 Romopgcw-7/18/2007
1522AMGN sales of Aranesp eat into J&J's Procrit Sales >> To: e_blastRay Rueb-7/18/2007
1521>>Affymax(R) Announces Phase 3 Development Plan for Hematide(TM) Monday Jutuck-7/17/2007
1520Uh-oh. J&J's sales of Procrit in the US down 14% during second quarter.steve kammerer-7/17/2007
1519Q3 P3-07 OUTCOMES TO ROCKET AMGN TO $100 + PER SHARE Denosumab: The Tempo of De_blastman-7/12/2007
1518>>Affymax(R) Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Montuck-6/25/2007
1517LONDON (MarketWatch) -- Novartis (NVS ) said a European Union committee has gratom pope-6/22/2007
1516Nature, Published online: 20 June 2007; | doi:10.1038/447899a Anaemic outlook idos-6/21/2007
1515Amgen's Image Problem Continues Amgen (AMGN: Nasdaq) By Rodman & Renshawmopgcw-6/18/2007
1514Amgen: Diversification Is Good MORGAN STANLEY RESEARCH 2007-06-04 19:46 (New Yormopgcw-6/12/2007
1513Today's generation of doctors[and their patients] are paying for their elderzeta1961-5/29/2007
1512Some Doctors Quit Injecting Drugs Over Costs By AVERY JOHNSON and HEATHER WON TDoc Bones-5/29/2007
1511ASCO's view on Medicare's recent proposal to not cover ESAs for MDS etc.zeta1961-5/28/2007
1510EU Body Backs Roche's Anemia Drug Friday May 25, 6:28 pm ET EU Body Backs david nordic-5/25/2007
1509>>Amgen Sees '07 Adjusted EPS 'In Line' With $4.30 Forecast>tuck-5/25/2007
1508nothing but bad news for Amgen these days. moreover the visit by one of the brokJGoren-5/25/2007
1507>> EU Body Backs Roche's Anemia Drug Mircera Last update: 5/25/2007 9:tuck-5/25/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News